Greenland Mines Ltd
GRMLW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001907223
In the last 90 days, Greenland Mines Ltd insiders filed 1 open-market purchase and 1 sale; 10 institutions reported holding it in 13F filings for Q3 2026, worth $655.7K in total; no superinvestor holds it.
Other share classesGRML
Holders of 5% or more of GRMLW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Greenland Mines Ltd, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Greenland Mines Ltd on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Greenland Mines Ltd, newest first.
No Schedule 13D or 13G filings on Greenland Mines Ltd are on file.
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Greenland Mines Ltd shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Oct 1, 20265:46 PM ET | Riad El-DadaDirector | 3.50K | $31.9K | Oct 1, 2026 | Goldman Sachs & Co. LLC | SEC |
| Jun 24, 20266:19 PM ET | Riad El-DadaDirector | 175.0K | $39.9K | Jun 24, 2026 | Goldman Sachs & Co. LLC | SEC |